Super Current Affairs

Science & Tech

ICMR AMRSN 2025: E. coli leads hospital samples as antibiotic resistance widens

18 November 20264 min1 source4 questionsStory 19 of 30

Source:Indian ExpressIndian Express

Subject: Health, Science and Technology: Antimicrobial Resistance and Public Health Infrastructure|Target exams: UPSC

Key points for Prelims: ICMR, AMRSN, Escherichia coli, Carbapenems, Methicillin-resistant Staphylococcus aureus, Klebsiella pneumoniae

Mains syllabus mapping

  • General Studies Paper 2: Health: issues relating to public health, diseases, and healthcare infrastructure; role of ICMR and other institutions
  • General Studies Paper 3: Science and Technology: developments and their applications in health; biotechnology and antimicrobial research

Antimicrobial Resistance Surveillance and Research Network (ICMR AMRSN): quick facts

Coordinating centre
ICMR Headquarters, New Delhi
Network structure
6 nodal centres in 4 tertiary care institutions and 16 regional centres
Pathogen groups
6 groups: diarrhoeagenic bacteria, enteric fever pathogens, Enterobacteriaceae causing sepsis, Gram-negative non-fermenters, Gram-positives including MRSA, and fungi

Key facts for one-day exams

  • ICMR published the AMRSN Annual Report 2025.
  • The report examined 1,13,008 positive samples from 30 large specialised hospitals.
  • The 34 smaller hospitals contributed 20,529 positive samples.
  • Carbapenem resistance was 91.1% among tested A. baumannii samples.
  • Methicillin resistance was 56.8% among tested Staphylococcus aureus samples.

ICMR AMRSN Annual Report 2025: why in the news?

The ICMR's AMRSN Annual Report 2025, released recently, documents a sharp decline in antibiotic effectiveness against common bacteria in hospital samples across India, including in smaller hospitals for the first time, raising concerns about treatment options for infections.

The Indian Council of Medical Research (ICMR) has warned that several common bacteria are no longer responding to antibiotics that doctors have used for years, according to its Antimicrobial Resistance Surveillance and Research Network (AMRSN) Annual Report 2025. The report, which examined 1,13,008 positive laboratory samples from 30 large specialised hospitals and 20,529 samples from 34 smaller secondary-care hospitals in 2025, found that Escherichia coli was the most commonly identified bacterium, accounting for 24.4 per cent of samples from large hospitals. The findings point to a worrying trend of declining antibiotic effectiveness across different levels of healthcare.

The report found that only 18.4 per cent of tested E. coli samples responded to cefotaxime and 24.7 per cent to ceftazidime, two commonly used antibiotics, while just 9 per cent responded to ciprofloxacin. Among tested Klebsiella pneumoniae samples, only 36.5 to 40.4 per cent responded to carbapenems, a group of powerful antibiotics, with even lower response in intensive-care unit samples. The report also found that 91.1 per cent of tested Acinetobacter baumannii samples showed resistance to carbapenems, and 56.8 per cent of tested Staphylococcus aureus samples were resistant to methicillin. For the first time, the report included separate findings on bloodstream infections among newborns, where Klebsiella pneumoniae was the most commonly identified bacterium, accounting for 25.1 per cent of tested samples.

Key features and how it works

  • Hospital network: tertiary care hospitals track trends in the antimicrobial susceptibility profile of clinically important bacteria and fungi, limited to human health.iamrsn.icmr.org.in
  • Nodal centres: each of the six pathogen groups has a nodal centre, for example AIIMS New Delhi for enteric fever pathogens, PGIMER Chandigarh for sepsis-causing Enterobacteriaceae and fungal infections, CMC Vellore for diarrhoeagenic bacteria and gram-negative non-fermenters, and JIPMER Puducherry for gram-positives including MRSA.iamrsn.icmr.org.in
  • Regional centres: 16 regional labs from tertiary care hospitals send data on a fixed number of isolates for each pathogen group, following ICMR standard operating procedures for bacteriology and mycology.iamrsn.icmr.org.in
  • Data system: ICMR runs a real-time web-based online AMR data entry system for collection, storage and analysis. Nodal centres validate data first.iamrsn.icmr.org.in
  • Molecular studies: nodal centres exchange organisms for in-depth molecular studies of clonality and transmission of drug-resistant pathogens.iamrsn.icmr.org.in

Related Static GK and comparison

  • Indian Council of Medical Research (ICMR): the apex body for biomedical research in India, funded through the Department of Health Research, Ministry of Health and Family Welfare; it was redesignated from the Indian Research Fund Association in 1949.
  • The AMRSN portal includes links to AMR ICMR Data, SOPs and Antimicrobial Stewardship Programme (AMSP) pages.iamrsn.icmr.org.in
  • Antimicrobial resistance (AMR): microbes evolve protection against antimicrobial drugs; MDR (multidrug-resistant) microbes are called superbugs; the WHO estimated that bacterial AMR directly caused 1.27 million deaths in 2019.
  • WHO GLASS: the Global Antimicrobial Resistance and Use Surveillance System, launched on 22 October 2015 as the first global collaborative effort to standardise AMR surveillance.WHO

AMRSN vs WHO GLASS

BasisICMR AMRSNWHO GLASS
Launch year201322 October 2015
ScopeHospital-based surveillance of clinically important bacteria and fungi in IndiaGlobal standardised collection of AMR and antimicrobial use data, including national systems
Implementing bodyICMR, under Department of Health ResearchWorld Health Organization
Pathogen focus6 pathogen groups aligned with the WHO priority pathogen list (2017)Common bacterial infections in humans (GLASS-AMR), plus fungi and gonorrhoea modules

Achievements

  • The 2025 report covered hospitals of two levels, large specialised and secondary-care, and for the first time gave separate findings on newborn bloodstream infections.
  • The network's pathogen groups align with the WHO priority pathogen list released in 2017.iamrsn.icmr.org.in

Challenges

  1. Resistance is high in the report: only 9% of tested E. coli samples responded to ciprofloxacin, and 91.1% of Acinetobacter baumannii samples were resistant to carbapenems.
  2. Data quality depends on consistent sampling across hospitals, so regional centres must follow the same SOPs.
  3. Surveillance covers hospital samples only, so resistance in community and animal settings is not captured.

Way forward

  • Outcome monitoring: link annual resistance data to changes in prescribing and track whether resistance falls.
  • Convergence with antimicrobial stewardship programmes and the One Health approach used by WHO GLASS.WHO

Antibiotic response in selected bacteria

BacteriumAntibioticResponse
E. coliCefotaxime18.4%
E. coliCeftazidime24.7%
E. coliCiprofloxacin9%
Shigella flexneriCiprofloxacin7.5%
Shigella sonneiCiprofloxacin8.9%

Key terms

Antimicrobial resistance:
Antimicrobial resistance is the ability of microorganisms to survive or grow despite medicines intended to act against them.
Antibiotic susceptibility testing:
Laboratory testing determines whether a bacterium is susceptible or resistant to particular antibiotics.
Carbapenems:
Carbapenems are a group of antibiotics used to treat serious bacterial infections, including some where other medicines fail.
Antibiotic stewardship:
Antibiotic stewardship is the careful and responsible use of antibiotics to improve treatment and limit resistance.

ICMR AMRSN Annual Report 2025: why it matters for exams

Exams: UPSC

Syllabus: Science and Technology: Microorganisms and antimicrobial resistance; Society: Public health and healthcare

Common mistake: Examiners may present 91.1% as carbapenem susceptibility rather than resistance: the figure is resistance among tested A. baumannii samples.

Mains practice questions

Question 1(GS-2 | 250 words | 15 marks)

Rising antimicrobial resistance is now visible even in smaller secondary-care hospitals in India, not only in large tertiary centres. Critically examine the factors behind this spread and evaluate the measures needed to contain it.

Answer outline

  • Introduction: Open by noting that the ICMR AMRSN Annual Report 2025 found falling antibiotic effectiveness across both large specialised and smaller secondary-care hospitals, making resistance a system-wide rather than a tertiary-care problem.
  • Body:
    • Explain the surveillance findings: E. coli as the most common isolate, low response to cefotaxime, ceftazidime and ciprofloxacin, and high carbapenem resistance in Acinetobacter baumannii.
    • Analyse drivers: indiscriminate or empirical antibiotic prescribing, self-medication and over-the-counter sales, weak infection prevention and hospital hygiene, and inadequate diagnostic laboratories in smaller hospitals.
    • Discuss the significance of newborn bloodstream infections caused by Klebsiella pneumoniae, which highlights vulnerability in neonatal care and hospital-acquired infection control.
    • Evaluate remedies: antimicrobial stewardship programmes, strengthening laboratory capacity and surveillance networks such as AMRSN, regulating sale of antibiotics, and the One Health approach linking human, animal and environmental health.
    • Note the role of ICMR in generating data for evidence-based treatment guidelines and policy.
  • Conclusion: Conclude that containing resistance requires coordinated stewardship, lab strengthening and public awareness across all tiers of care, with surveillance data used to guide prescribing and policy.

Question 2(GS-3 | 150 words | 10 marks)

Discuss the role of surveillance networks in generating evidence for public health policy, with reference to the findings of the ICMR AMRSN Annual Report 2025.

Answer outline

  • Introduction: Open by stating that the AMRSN report, analysing over one lakh positive samples from large hospitals and thousands from secondary-care hospitals, shows how systematic surveillance turns clinical data into policy evidence.
  • Body:
    • Explain how AMRSN collects and analyses isolate-level data across multiple hospitals, enabling tracking of resistance trends over time.
    • Cite findings that inform policy: declining response of E. coli and Klebsiella pneumoniae to key antibiotics, and the first-time inclusion of newborn bloodstream infections.
    • Discuss how such data can guide empirical treatment guidelines, antibiotic policy, and targeting of infection control resources.
    • Note limitations such as uneven laboratory capacity and the need to widen the network to more facilities.
  • Conclusion: Conclude that sustained, well-resourced surveillance is essential for timely, evidence-based antimicrobial policy.

Stuck? Get it in one tap

Practice questions

Pick an answer, then read the explanation.

  1. Q1Easy

    Which organisation publishes the Antimicrobial Resistance Surveillance and Research Network Annual Report 2025?

  2. Q2Hard

    Consider the following statements about the AMRSN Annual Report 2025:

    1. 1.The report included data from 34 smaller secondary-care hospitals for the first time.
    2. 2.Klebsiella pneumoniae was the most commonly identified bacterium in tested newborn bloodstream samples.
    3. 3.A. baumannii showed 91.1% susceptibility to carbapenems.

    Which of the statements given above are correct?

  3. Q3Medium

    What percentage of tested E. coli samples responded to ciprofloxacin in the AMRSN Annual Report 2025?

  4. Q4Medium

    Why should hospitals use local resistance data when selecting antibiotics for bacterial infections?

Frequently asked questions

1. What does the ICMR AMRSN Annual Report 2025 study?

The report examines antimicrobial resistance in microorganisms identified in hospital laboratory samples across India.

2. Which bacterium was most common in large hospitals in the AMRSN 2025 findings?

Escherichia coli accounted for 24.4% of samples from the large hospitals covered.

3. How many smaller hospitals were included in the AMRSN 2025 report?

The report included 34 smaller secondary-care hospitals, including 12 district hospitals.

4. Which bacterium was most common in tested newborn bloodstream samples?

Klebsiella pneumoniae accounted for 25.1% of tested samples from newborns aged 0-28 days.

All sources

Stories from the last 30 days on the same topic, state or exams

Science & TechJharkhandJPSC: Important

IIT Dhanbad receives ₹1.38 crore antibiotic research grant

  • Indian research institution: Indian Institute of Technology (Indian School of Mines), Dhanbad
  • Project title: Predictive Tools for Antibiotic Discovery in Klebsiella pneumoniae
Background GK: Antimicrobial resistanceNodal: IIT DhanbadDon't make this mistake!
4 questions · 3 minHindustan
Science & TechMadhya PradeshMPPSC: Important

ICMR approves free cancer testing lab at BMHRC, Bhopal

  • Full form of ICMR: Indian Council of Medical Research
  • Full form of BMHRC: Bhopal Memorial Hospital and Research Centre
Background GK: Indian Council of Medical ResearchNodal: ICMRDon't make this mistake!
4 questions · 2 minDainik Bhaskar
Science & TechJharkhandJPSC: Important

Nidan phase 2: AI prototype for kidney disease detection

  • Full form of ICMR: Indian Council of Medical Research
  • Research institution: National Institute of Technology Jamshedpur
Background GK: Artificial intelligenceNodal: NIT JamshedpurDon't make this mistake!
4 questions · 3 minHindustan